M&G plc’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.9M Buy
649,784
+506,538
+354% +$27.5M 0.14% 113
2026
Q1
$9.02M Buy
143,246
+1,266
+0.9% +$101K 0.05% 222
2025
Q4
$13.5M Buy
141,980
+10,108
+8% +$991K 0.07% 176
2025
Q3
$12.9M Buy
131,872
+107,854
+449% +$11.2M 0.07% 172
2025
Q2
$2.57M Buy
24,018
+69
+0.3% +$6.98K 0.01% 299
2025
Q1
$2.42M Buy
23,949
+8,111
+51% +$817K 0.01% 307
2024
Q4
$1.41M Buy
15,838
+43
+0.3% +$3.79K 0.01% 335
2024
Q3
$1.33M Buy
+15,795
New +$1.25M ﹤0.01% 333

Other funds holding BSX

M&G plc's BSX Position: Q2 2026 in Review

M&G plc increased its Boston Scientific (BSX) stake by 354% in Q2 2026, buying an estimated $27.5M and bringing the position to 649,784 shares worth $27.9M. The position accounts for 0.14% of the portfolio, ranked #113.

M&G plc first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • M&G plc held 649,784 shares of Boston Scientific worth $27.9M as of Q2 2026.
  • M&G plc bought 506,538 Boston Scientific shares in Q2 2026, an estimated $27.5M.
  • Boston Scientific made up 0.14% of M&G plc's portfolio in Q2 2026, its #113 holding.
  • M&G plc first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.